Susumu Kitamura

3.6k total citations
6 papers, 220 citations indexed

About

Susumu Kitamura is a scholar working on Dermatology, Surgery and Epidemiology. According to data from OpenAlex, Susumu Kitamura has authored 6 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Dermatology, 2 papers in Surgery and 2 papers in Epidemiology. Recurrent topics in Susumu Kitamura's work include Systemic Lupus Erythematosus Research (2 papers), Asthma and respiratory diseases (2 papers) and Microscopic Colitis (2 papers). Susumu Kitamura is often cited by papers focused on Systemic Lupus Erythematosus Research (2 papers), Asthma and respiratory diseases (2 papers) and Microscopic Colitis (2 papers). Susumu Kitamura collaborates with scholars based in Japan, United States and Germany. Susumu Kitamura's co-authors include Mamitaro Ohtsuki, Atsuyuki Igarashi, Xin Huang, Mary Flack, Hideki Fujita, Joaquin Valdes, Masao Watanabe, Akimichi Morita, Shinichi Imafuku and Takashi Matsuyama and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and The Journal of Dermatology.

In The Last Decade

Susumu Kitamura

6 papers receiving 220 citations

Peers

Susumu Kitamura

IMMUN

DERMA

RHEUM

PHYSI

HEMAT

Maximilian Reinhardt Germany

Enes Hajdarbegovic Netherlands

Ghislaine Annie Clarisse Isabwe Canada

Cristina Mugheddu Italy

Giulia Pavia Italy

Luigi Gargiulo Italy

Renata Gontijo Lima United States

Carole Guillet Switzerland

Fan Emily Yang United States

Inge M. G. J. Bronckers Netherlands

Maximilian Reinhardt Germany

Susumu Kitamura

184 ×1.3

IMMUN

136 ×1.0

DERMA

115 ×1.8

RHEUM

39 ×0.9

PHYSI

23 ×0.6

HEMAT

Citations per year, relative to Susumu Kitamura Susumu Kitamura (= 1×) peers Maximilian Reinhardt

Countries citing papers authored by Susumu Kitamura

Since Specialization

Citations

This map shows the geographic impact of Susumu Kitamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susumu Kitamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susumu Kitamura more than expected).

Fields of papers citing papers by Susumu Kitamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susumu Kitamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susumu Kitamura. The network helps show where Susumu Kitamura may publish in the future.

Co-authorship network of co-authors of Susumu Kitamura

This figure shows the co-authorship network connecting the top 25 collaborators of Susumu Kitamura. A scholar is included among the top collaborators of Susumu Kitamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susumu Kitamura. Susumu Kitamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Morita, Akimichi, Hidetoshi Takahashi, Kentaro Ozawa, et al.. (2020). Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results. The Journal of Dermatology. 48(1). 3–13. 13 indexed citations

2.

Kameda, Hideto, Tsutomu Takeuchi, Kunihiro Yamaoka, et al.. (2020). Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study. Lara D. Veeken. 59(11). 3303–3313. 48 indexed citations

3.

Ohtsuki, Mamitaro, Hideki Fujita, Masao Watanabe, et al.. (2019). Efficacy and safety of risankizumab in Japanese patients with moderate to severe plaque psoriasis: Results from the SustaIMM phase 2/3 trial. The Journal of Dermatology. 46(8). 686–694. 79 indexed citations

4.

Morita, Akimichi, Hidetoshi Takahashi, Kentaro Ozawa, et al.. (2019). Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. The Journal of Dermatology. 46(9). 745–751. 16 indexed citations

5.

Morita, Akimichi, Fumikazu Yamazaki, Takashi Matsuyama, et al.. (2018). Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open‐label phase 3 study. The Journal of Dermatology. 45(12). 1371–1380. 54 indexed citations

6.

Tanaka, Yoshiya, Tsutomu Takeuchi, Kunihiro Yamaoka, et al.. (2018). SAT0257 A phase 2b/3 randomised, placebo-controlled, double-blind study of upadacitinib, a selective jak1 inhibitor, in japanese patients with active rheumatoid arthritis and inadequate response to conventional synthetic dmards. Annals of the Rheumatic Diseases. 77. 991–992. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact